Spanish Menopause Society position statement: Use of denosumab in postmenopausal women

被引：0

作者：

Canoa, Antonio ^{[1
]}

Manuel Silvan, Jose ^{[2
]}

Estevez, Antonio ^{[3
]}

Baro, Francesc ^{[4
]}

Villero, Jose ^{[5
]}

Quereda, Francisco ^{[6
]}

Ferrer, Javier ^{[7
]}

Mendoza, Nicolas ^{[8
]}

Sanchez-Borrego, Rafael ^{[9
]}

机构：

[1] Univ Valencia, Hosp Univ Dr Peset, Valencia, Spain

[2] Univ Seville, Hosp Univ Virgen Bocio, Seville, Spain

[3] Hosp Univ Valme, Seville, Spain

[4] Univ Barcelone, Hosp Vall Hebron, Barcelona, Spain

[5] Hosp Reina Sofia, Cordoba, Spain

[6] Univ Miguel Hernandez, Hosp Univ San Juan Alicante, Alicante, Spain

[7] Univ Oviedo, Hosp Univ Cent Asturias, Oviedo, Spain

[8] Univ Granada, Dept Obstet & Gynecol, Granada, Spain

[9] Clin Diatros, Barcelona, Spain

来源：

MATURITAS | 2014年 / 79卷 / 01期

关键词：

Denosumab; Postmenopausal osteoporosis; Breast cancer; BONE-MINERAL DENSITY; PHASE-2; CLINICAL-TRIAL; COST-EFFECTIVENESS; ZOLEDRONIC ACID; BREAST-CANCER; ECONOMIC-EVALUATION; OSTEOPOROTIC WOMEN; FREEDOM EXTENSION; PROSTATE-CANCER; METASTASES;

D O I：

10.1016/j.maturitas.2014.06.011

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Denosumab is a new drug developed for the treatment of osteoporosis. Moreover, increasing evidences link denosumab with benefits in cancer, an area of interest for those in charge of the postmenopausal health. Denosumab has shown efficacy in the control of bone loss associated with hypogonadic states created by chemotherapy in breast and other cancers. Moreover, some studies reveal efficacy in reducing the progression of metastases. A panel of experts from the Spanish Menopause Society has met to develop usage recommendations based on the best available evidence. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：117 / 121

页数：5

共 50 条

[21] NAMS releases updated position statement on the use of estrogen and progestogen in perimenopausal and postmenopausal women
Graham, Lisa
AMERICAN FAMILY PHYSICIAN, 2007, 76 (02) : 295 - 297
[22] Recommendations of the Spanish Menopause Society on the consumption of omega-3 polyunsaturated fatty acids by postmenopausal women
Sanchez-Borrego, Rafael
von Schacky, Clemens
Alonso Osorio, Maria Jose
Llaneza, Placido
Pinto, Xavier
Losa, Fernando
Concepcion Navarro, Ma
Lubian, Daniel
Mendoza, Nicolas
MATURITAS, 2017, 103 : 71 - 77
[23] Optimizing the menopause transition: Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause
Hamoda, Haitham
Mukherjee, Annice
Morris, Edward
Baldeweg, Stephanie E.
Jayasena, Channa N.
Briggs, Paula
Moger, Sara
CLINICAL ENDOCRINOLOGY, 2024, 101 (01) : 60 - 61
[24] The 2023 nonhormone therapy position statement of The North American Menopause Society
Shufelt, Chrisandra L.
Brown, Vivien
Carpenter, Janet S.
Chism, Lisa Astalos
Faubion, Stephanie S.
Joffe, Hadine
Kling, Juliana M.
Soares, Claudio N.
Thurston, Rebecca C.
MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2023, 30 (06): : 573 - 590
[25] Denosumab: A Review of its Use in Postmenopausal Women with Osteoporosis
Scott, Lesley J.
DRUGS & AGING, 2014, 31 (07) : 555 - 576
[26] Denosumab: A Review of its Use in Postmenopausal Women with Osteoporosis
Lesley J. Scott
Drugs & Aging, 2014, 31 : 555 - 576
[27] The 2012 Hormone Therapy Position Statement of The North American Menopause Society
不详
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (03): : 257 - 271
[28] The 2017 hormone therapy position statement of The North American Menopause Society
Pinkerton, JoAnn V.
Aguirre, Fernando Sanchez
Blake, Jennifer
Cosman, Felicia
Hodis, Howard
Hoffstetter, Susan
Kaunitz, Andrew M.
Kingsberg, Sheryl A.
Maki, Pauline M.
Manson, JoAnn E.
Marchbanks, Polly
McClung, Michael R.
Nachtigall, Lila E.
Nelson, Lawrence M.
Pace, Diane Todd
Reid, Robert L.
Sarrel, Phillip M.
Shifren, Jan L.
Stuenkel, Cynthia A.
Utian, Wulf H.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (07): : 728 - 753
[29] The 2017 hormone therapy position statement of The North American Menopause Society
不详
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (11): : 1362 - 1387
[30] 2017 Hormone Therapy Position Statement of The North American Menopause Society
Pinkerton, Joann V.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1418 - 1418

← 1 2 3 4 5 →